Skip to main content

Abstract

Opioids are a group of compounds that interact at the opioid receptors that are primarily used acute and chronic pain relief. There are many different opioids that differ in their mode of action, duration of action, abuse potential, adverse effects, route of administration, and potency.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

CNCP:

Chronic non-cancerous pain

COT:

Chronic opioid therapy

ECGs:

Electrocardiograms

ER:

Extended release

GABA:

Gamma-aminobutyric acid

IR:

Immediate release

MHRA:

Medicines and Healthcare products Regulatory Agency

QTc:

Rate corrected QT

SL:

Sublingual

References

  1. Breasted JG. Ancient records of Egypt. University of Chicago Oriental Institute Publications. vol. III. Chicago: University of Chicago Press; 1930. p. 217.

    Google Scholar 

  2. Trescot AM, Datta S, Lee M, Hansen H. Opioid pharmacology. Pain Physician. 2008;11:S5–62 [opioids special issue].

    PubMed  Google Scholar 

  3. Warner EA. Opioids for the treatment of noncancer pain. Am J Med. 2012;125(12):1155–61.

    Article  CAS  PubMed  Google Scholar 

  4. Nestler EJ. Molecular basis on longterm plasticity underlying addiction. Nat Rev Neurosci. 2001;2:119–28.

    Article  CAS  PubMed  Google Scholar 

  5. Fukuda K. Intravenous opioid anesthetics. In: Miller RD, editor. Miller’s anesthesia. 6th ed. Philadelphia: Elsevier; 2005.

    Google Scholar 

  6. Martell BA, O’Connor PG, Kerns RD, Becker WC, Morales KH, Kosten TR, Fiellin DA. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med. 2007;146(2):116–27.

    Article  PubMed  Google Scholar 

  7. Noble M, Treadwell JR, Treager SJ, Coates VH, Wiffen PJ, Akafomo C, Schoelles KM. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010;1, CD006605.

    PubMed  Google Scholar 

  8. Title 12, Chapter 13, Part B12: Schedules of controlled substances. DEA. www.ibt.tamhsc.edu/safety_office/pdf_stuff/DEA-Sch_%20of_Cont_Sub.Pdf

  9. Chou R, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113–30.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Manchikanti L, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 1—evidence assessment. Pain Physician. 2012;15:S1–66.

    PubMed  Google Scholar 

  11. Manchikanti L, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2—guidance. Pain Physician. 2012;15:S66–116.

    Google Scholar 

  12. Ackerman SJ, Knight T, Schein J, et al. Risk of constipation in patients prescribed fentanyl transdermal system or oxycodone hydrochloride controlled-release in a California Medicaid population. Consult Pharm. 2004;19:118–32.

    Article  PubMed  Google Scholar 

  13. Verhamme KM, Sturkenboom MC, Stricker BH, Bosch R. Drug-induced urinary retention: incidence, management and prevention. Drug Saf. 2008;31(5):373–88.

    Article  CAS  PubMed  Google Scholar 

  14. Ganesh A, Maxwell LG. Pathophysiology and management of opioid-induced pruritis. Drugs. 2007;67(16):2323–32.

    Article  CAS  PubMed  Google Scholar 

  15. Swegle JM, Logemann C. Management of common opioid-induced adverse effects. Am Fam Physician. 2006;74(8):1347–54.

    PubMed  Google Scholar 

  16. Lee M, Silverman S, Hansen H, Patel V, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011;14:145–61.

    PubMed  Google Scholar 

  17. Kishner S. Opioid equivalents. eMedicine from WebMD, August 7; 2012.

    Google Scholar 

  18. Derby S, Chin J, Portenoy RK. Systemic opioid therapy for chronic cancer pain: practical guidelines for converting drugs and routes of administration. CNS Drugs. 1999;9(2):99–109.

    Article  Google Scholar 

  19. Jaffe JH, Martin WR. Opioid analgesics and antagonists. In: Gilman AG, Goodman LS, Rall TW, et al., editors. Goodman and Gilman’s the pharmacological basis of therapeutics. 7th ed. New York: Macmillan Publishing Company; 1985. p. 491–531.

    Google Scholar 

  20. MHRA and Commission on Human Medicines. Risk of QT interval prolongation with methadone. Report no.: 31; 2006.

    Google Scholar 

  21. Moss AJ. Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol. 1993;72:23B–5B.

    Article  CAS  PubMed  Google Scholar 

  22. Katchman AN, McGroary KA, Kilborn MJ, et al. Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents. J Pharmacol Exp Ther. 2002;303:688–94.

    Article  CAS  PubMed  Google Scholar 

  23. Mayet S, Gossop M, Lintzeris N, Markides V, Strang J. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation? Drug Alcohol Rev. 2011;30(4):388–96.

    Article  PubMed  Google Scholar 

  24. Kahn LH, Alderfer RJ, Graham DJ. Seizures reported with Tramadol. JAMA. 1997;278:1661.

    Article  CAS  PubMed  Google Scholar 

  25. Lewis JW. Buprenorphine. Drug Alcohol Depend. 1985;14:363–72.

    Article  CAS  PubMed  Google Scholar 

  26. Tzschentke TM, Christoph T, Kögel B, Schiene K, Hennies HH, Englberger W, Haurand M, Jahnel U, Cremers TI, Friderichs E, De Vry J. Tapentadol HCl: a novel mu-opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties. J Pharmacol Exp Ther. 2007;323(1):265–76.

    Article  CAS  PubMed  Google Scholar 

  27. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112–20.

    Article  CAS  PubMed  Google Scholar 

  28. Ferrel B, Argoff CE, Epplin J, Fine P, Gloth 3rd FM, Herr K, Katz JD, Mehr DR, Reid MC, Reisner L. American geriatrics society panel on the pharmacological management of persisting pain in older persons. Pain Med. 2009;10(6):1062–83.

    Article  Google Scholar 

  29. Brookoff D. Abuse potential of various opioid medications. J Gen Intern Med. 1993;8(12):688–90.

    Article  CAS  PubMed  Google Scholar 

  30. Alford D, Compton P, Samet J. Acute pain management for patients receiving maintenance methadone or buprenorphine therapy. Ann Intern Med. 2006;144(2):127–34.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  31. Kehlet H, Dahl JB. The value of “multimodal” or “balanced analgesia” in postoperative pain treatment. Anesth Analg. 1993;77:1048–56.

    Article  CAS  PubMed  Google Scholar 

  32. Botney M, Fields HL. Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system. Ann Neurol. 1983;13:160–4.

    Article  CAS  PubMed  Google Scholar 

  33. Mitra S, Sinatra RS. Perioperative management of acute pain in the opioid-dependent patient. Anesthesiology. 2004;101:212–27.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stephen Kishner M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kishner, S., Tran, J.P. (2015). Opioid Medications. In: Sackheim, K. (eds) Pain Management and Palliative Care. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2462-2_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2462-2_14

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-2461-5

  • Online ISBN: 978-1-4939-2462-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics